chrX-102126844-T-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_080390.4(TCEAL2):​c.14T>A​(p.Phe5Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,203,862 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.00012 ( 0 hom. 42 hem. )

Consequence

TCEAL2
NM_080390.4 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.550
Variant links:
Genes affected
TCEAL2 (HGNC:29818): (transcription elongation factor A like 2) This gene encodes a member of the transcription elongation factor A (SII)-like (TCEAL) gene family. Members of this family contain TFA domains and may function as nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner. Multiple family members are located on the X chromosome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031745046).
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TCEAL2NM_080390.4 linkuse as main transcriptc.14T>A p.Phe5Tyr missense_variant 3/3 ENST00000372780.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TCEAL2ENST00000372780.6 linkuse as main transcriptc.14T>A p.Phe5Tyr missense_variant 3/31 NM_080390.4 P1
TCEAL2ENST00000476749.1 linkuse as main transcriptn.799T>A non_coding_transcript_exon_variant 2/21
TCEAL2ENST00000329035.2 linkuse as main transcriptc.14T>A p.Phe5Tyr missense_variant 3/35 P1
TCEAL2ENST00000651085.1 linkuse as main transcriptn.153+399T>A intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112249
Hom.:
0
Cov.:
24
AF XY:
0.0000581
AC XY:
2
AN XY:
34447
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000939
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000752
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000398
AC:
7
AN:
175852
Hom.:
0
AF XY:
0.0000482
AC XY:
3
AN XY:
62220
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000386
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000754
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000123
AC:
134
AN:
1091558
Hom.:
0
Cov.:
31
AF XY:
0.000117
AC XY:
42
AN XY:
359426
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000296
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000155
Gnomad4 OTH exome
AF:
0.0000656
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112304
Hom.:
0
Cov.:
24
AF XY:
0.0000580
AC XY:
2
AN XY:
34512
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000938
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000752
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000680
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 28, 2023The c.14T>A (p.F5Y) alteration is located in exon 3 (coding exon 1) of the TCEAL2 gene. This alteration results from a T to A substitution at nucleotide position 14, causing the phenylalanine (F) at amino acid position 5 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.044
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.024
DANN
Benign
0.26
DEOGEN2
Benign
0.0018
T;T
FATHMM_MKL
Benign
0.0020
N
LIST_S2
Benign
0.078
T;.
M_CAP
Benign
0.00057
T
MetaRNN
Benign
0.032
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.5
N;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
1.0
N;N
REVEL
Benign
0.0010
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.072
MutPred
0.27
Gain of phosphorylation at F5 (P = 0.0273);Gain of phosphorylation at F5 (P = 0.0273);
MVP
0.043
MPC
0.15
ClinPred
0.022
T
GERP RS
-6.8
Varity_R
0.056
gMVP
0.0074

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201161155; hg19: chrX-101381816; COSMIC: COSV61197639; API